Versago Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $1.65M

  • Investors
  • 1

Versago General Information

Description

Developer of a medical technology designed to facilitate safe and reliable vascular procedures. The company's technology offers a patented system that displaces multiple traditional devices and applications in apheresis and chemotherapy, enabling patients to get advanced treatments without needle sticks or device misses.

Contact Information

Website
www.versagovascularaccess.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 375 West Street
  • West Bridgewater, MA 02379
  • United States
+1 (508) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Versago Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Corporate (Series A) 25-Feb-2016 $1.65M 00.000 000.00 Completed Startup
1. Angel (individual) 06-Aug-2015 00000 00000 Completed Startup
To view Versago’s complete valuation and funding history, request access »

Versago Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view Versago’s complete cap table history, request access »

Versago Patents

  • 77

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 9

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Versago Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3086211-A1 Medical access ports, transfer devices and methods of use thereof Pending 21-Dec-2017 0000000000
EP-3727558-A4 Medical access ports, transfer devices and methods of use thereof Pending 21-Dec-2017 0000000000 0
EP-3727558-A1 Medical access ports, transfer devices and methods of use thereof Pending 21-Dec-2017 0000000000
US-20220072222-A1 Medical access ports, transfer devices and methods of use thereof Pending 21-Dec-2017 0000000000
US-11058815-B2 Medical access ports, transfer devices and methods of use thereof Active 21-Dec-2017 A61M1/3653
To view Versago’s complete patent history, request access »

Versago Executive Team (3)

Name Title Board Seat Contact Info
Andrea Patisteas Co-Founder, Chief Executive Officer & Board Member
Ross Garofalo Chief Financial Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Versago Board Members (2)

Name Representing Role Since
Andrea Patisteas Versago Co-Founder, Chief Executive Officer & Board Member 000 0000
Steven Tallarida Self Board Member 000 0000
To view Versago’s complete board members history, request access »

Versago Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Versago Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Primo Medical Group Corporation Minority 000 0000 000000 0
To view Versago’s complete investors history, request access »

Ready to get started?

Request a free trial